Retro Biosciences has 6 close competitors: Formation Bio, Insitro, BenevolentAI.
Sector, valuation and status for each competitor.
competitor›
competitor›
competitor›
competitor›
competitor›
competitor›A private valuation and a public market cap share one column; each row names its basis and date.
Formation BioInsitroBenevolentAIAtomwiseColossal BiosciencesEcovativa DesignAnti-aging biotech startup developing therapies to extend healthy human lifespan by addressing cellular drivers of aging through regenerative medicine
Retro Biosciences competes with 6 companies here: Formation Bio, Insitro, BenevolentAI, Atomwise, Colossal Biosciences, Ecovativa Design.
Retro Biosciences was last valued at $1.8B (post-money, May 2026). That price was agreed in one transaction and holds until the next round. A listed competitor is repriced every trading session.
The last valuation is $1.8B.
Lead investors for each round are in the funding timeline.
The closest biotechnology peers are on the competitors page.
The routes section explains what is realistically available for a company at this stage.
No. Retro Biosciences is a private company; its shares do not trade on a public exchange.
Perpetual markets for stocks, gold, indices and pre-IPO names — settled on-chain, no wallet-to-exchange transfers.
